Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation
Worldwide, breast cancer (BC) is the second most common cancer. Pharmacologically targeting cyclin-dependent kinase 4 and 6 (CDK4 & 6) has proven to be a successful therapeutic approach in patients with estrogen receptor-positive ...
Jul 6, 2022
0
6